Neuromodulation Advantage Leverage Eybna's BNA AI-Platform to develop data-driven botanical ingredients for wellness beverages. Offer pilot collaborations to validate neuromodulatory claims across focus, sleep, mood, and inflammation categories, using in-silico modeling, in-vitro assays, EEG studies, and consumer trials as proof points.

Strategic Partnerships Growth Capitalize on existing collaborations with Gat Foods and the Azuca partnership to target large beverage manufacturers and co-packers in the US and EU. Propose joint R&D programs and private-label opportunities to accelerate market entry with science-backed botanicals.

Global Footprint Benefit from a global development and distribution backbone, with R&D in Israel and the Netherlands and commercial hubs in Los Angeles and Berlin, enabling regional co-development, regulatory alignment, and multi-market rollouts across multiple markets.

Premium Quality & Scale Position as a supplier of pharmaceutical-grade botanical ingredients for beverages and wellness products, offering end-to-end development from aroma to function and scalable manufacturing to support brands from pilot to full production.

Market Traction & Growth Leverage demonstrated revenue traction and a diverse client base to approach mid-size and large beverage brands seeking innovative botanicals. Present case studies from Functional Line and NT-VRL programs to secure pilots and exclusive supply agreements.